Pharma Journalist -

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the United Kingdom’s National Institute for Health and Care Excellence (NICE) has published positive…
Read More...

SMi Group are delighted to welcome expertise from a senior panel of big pharma and cold chain organisations and regulatory bodies, at the 13th annual industry leading conference on Cold…
Read More...

Cambrex Corporation announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy. The investment will be in the construction of a new 150m²…
Read More...

AbCellera Biologics announced the successful completion of the first phase of its collaboration with Denali Therapeutics. Under the collaboration, AbCellera applied its single-cell…
Read More...

Asterias Biotherapeutics announced enrollment and dosing of the first subject in the first-in-human Phase 1 clinical trial of AST-VAC2 in the United Kingdom. This initial clinical…
Read More...

Eisai Inc. announced it will launch the Eisai Center for Genetics Guided Dementia Discovery, which will harness the power of human genetics to develop next-generation medicines for…
Read More...

Nordic Nanovector ASA announces that the US Food & Drug Administration (FDA) has granted Fast Track designation to Betalutin (177Lu-lilotomab satetraxetan) for the treatment of…
Read More...

SMi are delighted to have interviewed, speaker, Ioannis Papantoniou, ATMP Bioprocessing Coordinator, Skeletal Biology and Engineering Research Centre, KU Leuven regarding his thoughts…
Read More...

SMi Group are delighted to welcome the expertise from a senior panel of big pharma and ophthalmic organisations, as well as regulatory bodies, at the 2nd annual Ophthalmic Drugs 2018…
Read More...

LabCorp announced that it has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and…
Read More...